These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34616409)

  • 21. NEUT-SFL in Patients with COVID-ARDS: A Novel Biomarker for Thrombotic Events?
    Stiel L; Rabouel Y; Debliquis A; Pointurier V; Mootien J; Kuteifan K
    Dis Markers; 2021; 2021():4361844. PubMed ID: 34840629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
    Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
    In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
    Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
    J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
    Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
    J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival.
    Lesur O; Kokis A; Hermans C; Fülöp T; Bernard A; Lane D
    Crit Care Med; 2000 Dec; 28(12):3814-22. PubMed ID: 11153619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS.
    Sarma A; Christenson SA; Byrne A; Mick E; Pisco AO; DeVoe C; Deiss T; Ghale R; Zha BS; Tsitsiklis A; Jauregui A; Moazed F; Detweiler AM; Spottiswoode N; Sinha P; Neff N; Tan M; Serpa PH; Willmore A; Ansel KM; Wilson JG; Leligdowicz A; Siegel ER; Sirota M; DeRisi JL; Matthay MA; ; Hendrickson CM; Kangelaris KN; Krummel MF; Woodruff PG; Erle DJ; Calfee CS; Langelier CR
    Nat Commun; 2021 Aug; 12(1):5152. PubMed ID: 34446707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia.
    Liao L; Yang GH
    J Med Virol; 2021 May; 93(5):2979-2987. PubMed ID: 33506950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An increase in CD62L
    Spijkerman R; Jorritsma NKN; Bongers SH; Bindels BJJ; Jukema BN; Hesselink L; Hietbrink F; Leenen LPH; van Goor HMR; Vrisekoop N; Kaasjager KAH; Koenderman L;
    Scand J Immunol; 2021 Jun; 93(6):e13023. PubMed ID: 33482019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metoprolol in Critically Ill Patients With COVID-19.
    Clemente-Moragón A; Martínez-Milla J; Oliver E; Santos A; Flandes J; Fernández I; Rodríguez-González L; Serrano Del Castillo C; Ioan AM; López-Álvarez M; Gómez-Talavera S; Galán-Arriola C; Fuster V; Pérez-Calvo C; Ibáñez B
    J Am Coll Cardiol; 2021 Sep; 78(10):1001-1011. PubMed ID: 34474731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphoinositide 3-Kinase δ Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection.
    Scott J; Ruchaud-Sparagano MH; Musgrave K; Roy AI; Wright SE; Perry JD; Conway Morris A; Rostron AJ; Simpson AJ
    J Immunol; 2021 Oct; 207(7):1776-1784. PubMed ID: 34497151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intriguing commonality of NETosis between COVID-19 & Periodontal disease.
    Gupta S; Sahni V
    Med Hypotheses; 2020 Nov; 144():109968. PubMed ID: 32534340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
    Venet F; Cour M; Rimmelé T; Viel S; Yonis H; Coudereau R; Amaz C; Abraham P; Monard C; Casalegno JS; Brengel-Pesce K; Lukaszewicz AC; Argaud L; Monneret G;
    Crit Care; 2021 Apr; 25(1):140. PubMed ID: 33845874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia.
    Nicolai L; Leunig A; Brambs S; Kaiser R; Joppich M; Hoffknecht ML; Gold C; Engel A; Polewka V; Muenchhoff M; Hellmuth JC; Ruhle A; Ledderose S; Weinberger T; Schulz H; Scherer C; Rudelius M; Zoller M; Keppler OT; Zwißler B; von Bergwelt-Baildon M; Kääb S; Zimmer R; Bülow RD; von Stillfried S; Boor P; Massberg S; Pekayvaz K; Stark K
    J Thromb Haemost; 2021 Feb; 19(2):574-581. PubMed ID: 33217134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1.
    Blanch-Ruíz MA; Sánchez-López A; Ríos-Navarro C; Ortega-Luna R; Collado-Díaz V; Orden S; Martínez-Cuesta MA; Esplugues JV; Álvarez Á
    Br J Pharmacol; 2023 Jun; 180(11):1516-1532. PubMed ID: 36541109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy.
    Dentone C; Vena A; Loconte M; Grillo F; Brunetti I; Barisione E; Tedone E; Mora S; Di Biagio A; Orsi A; De Maria A; Nicolini L; Ball L; Giacobbe DR; Magnasco L; Delfino E; Mastracci L; Mangerini R; Taramasso L; Sepulcri C; Pincino R; Bavastro M; Cerchiaro M; Mikulska M; Bruzzone B; Icardi G; Frisoni P; Gratarola A; Patroniti N; Pelosi P; Bassetti M
    BMC Infect Dis; 2021 Apr; 21(1):353. PubMed ID: 33858331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
    Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
    Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophils in COVID-19: recent insights and advances.
    Li J; Zhang K; Zhang Y; Gu Z; Huang C
    Virol J; 2023 Aug; 20(1):169. PubMed ID: 37533131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.